IL33 and Alzheimer disease: Cytokines IL-25, IL-33, and TSLP play an important key role in the pro-inflammatory milieu of AD by stimulating Th2 cells directly or indirectly through the stimulation of multiple immune cells, including dendritic cells, mast cells, and eosinophils, and immunomodulatory disorders and contribute to barrier dysfunction [7,8].